Matthew Maxwell Donley

Insider Reports History

Location
Edmonton
Signature
/s/ Matthew Maxwell Donley
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Matthew Maxwell Donley:

Company Role Class Num Shares Value Price $ Report Date Ownership
Aurinia Pharmaceuticals Inc. Chief Operating Officer Common Stock 695,801 $11,098,025 $15.95 02 Jan 2026 Direct
Aurinia Pharmaceuticals Inc. Chief Operating Officer Employee Stock Option (right to buy) 126,416 28 Feb 2025 Direct

Insider Reports Filed by Matthew Maxwell Donley

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AUPH Aurinia Pharmaceuticals Inc. 02 Jan 2026 2 -$682,453 4 Chief Operating Officer 05 Jan 2026, 16:12
AUPH Aurinia Pharmaceuticals Inc. 28 Feb 2025 5 -$994,425 4 Chief Operating Officer 04 Mar 2025, 20:56
AUPH Aurinia Pharmaceuticals Inc. 06 Mar 2024 1 -$224,064 4 EVP, Ops & Strategy 07 Mar 2024, 16:43
AUPH Aurinia Pharmaceuticals Inc. 20 Feb 2024 1 $0 4 EVP, Ops & Strategy 22 Feb 2024, 16:31
AUPH Aurinia Pharmaceuticals Inc. 02 Mar 2023 1 $0 4 EVP, Ops & Strategy 06 Mar 2023, 15:29
AUPH Aurinia Pharmaceuticals Inc. 21 Nov 2022 1 +$46,600 4 Ex VP, Internal Operations 23 Nov 2022, 15:04
AUPH Aurinia Pharmaceuticals Inc. 02 Mar 2022 4 -$36,655 4 Ex VP, Intern'l Operations 04 Mar 2022, 15:12
AUPH Aurinia Pharmaceuticals Inc. 11 May 2021 1 +$99,739 4 Ex VP, Intern'l Operations 12 May 2021, 16:34